Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
2 Monotherapy is no longer available in the USA since Jan 2023, and lixisenatide-glargine (iGlarLixi) has been approved for type 2 diabetes
The April 2026 FDA action removes them from the Category 2 restricted compounding list effective April 23, 2026, and the FDAs Pharmacy Compounding Advisory Committee will review their compounding eligibility under 503A at its July 23-24, 2026 meeting
IGF-1 LR3 is primarily used to promote muscle and tissue repair, stimulate cell growth, and improve fat metabolism Whats Inside IGF LR3 1mg IGF-1 LR3 is a modified version of insulin-like growth factor-1 designed to last longer in the bloodstream and enhance cellular repair, muscle growth, and fat metabolism
Zhu, D., Su, Y., Fu, B
BAC Water (Bacteriostatic Water) Research Diluent Overview
US$ 20.42
US$ 26.65
US$ 22.17
US$ 26.96
US$ 20.66
US$ 24.79
US$ 24.27
US$ 29.35
US$ 28.09
US$ 25.43
US$ 26.78
